Provenance du réseau au premier degré de Alan Mark Rauch
Entité | Type d'entité | Industrie | |
---|---|---|---|
Glaxo Wellcome, Inc.
22
| Extinct | Pharmaceuticals: Major | 22 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Alan Mark Rauch via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ALLERGAN, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Sales & Marketing Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing General Counsel Corporate Officer/Principal | |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Neusentis, Inc.
Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member | |
Ziarco, Inc. | Director/Board Member | ||
GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Undergraduate Degree Corporate Officer/Principal Masters Business Admin | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Executive Officer | |
McGill University | College/University | Undergraduate Degree | |
OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
ALAUNOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
Project HOPE-The-People-To-People HealthFoundation, Inc.
Project HOPE-The-People-To-People HealthFoundation, Inc. Medical/Nursing ServicesHealth Services Project HOPE-The-People-To-People HealthFoundation, Inc. provides solutions to health problems. The firm trains health professionals and build medical facilities in areas devastated by conflict, natural disasters, and poverty. It addresses infectious diseases, health professional education, women's and children's health, humanitarian assistance, and the need for health systems and facilities. The company was founded by William B. Walsh in 1958 and is headquartered in Millwood, VA. | Medical/Nursing Services | Director/Board Member | |
North Carolina State University College of Sciences Foundation | Corporate Officer/Principal | ||
Glaxo, Inc. | Chairman Compliance Officer | ||
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Operating Officer General Counsel | |
Empower Energies Clean Infrastructure LLC
Empower Energies Clean Infrastructure LLC SemiconductorsElectronic Technology Empower Energies, Inc. operates as a full-service renewable energy program manager. It provides customized renewable energy project development, construction, financing and acquisition solutions. The company was founded by Len Jornlin in 2010 and is headquartered in Bethesda, MD. | Semiconductors | Director/Board Member | |
TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Johns Hopkins Bloomberg School of Public Health | College/University | Director/Board Member Director/Board Member | |
OBSEVA SA | Pharmaceuticals: Major | Director/Board Member | |
The Fuqua School of Business | College/University | Masters Business Admin Corporate Officer/Principal | |
North Carolina Glaxosmithkline Foundation | Chairman Director/Board Member | ||
RENEO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
INOZYME PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
SYNLOGIC, INC. | Biotechnology | Director/Board Member | |
AKOUOS | Biotechnology | Director/Board Member | |
SpliceBio SL
SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Shape Therapeutics, Inc. operates as a biotechnology firm. It offers genome medicine. The company was founded by Francois Vigneault and John D. Suliman in 2018 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
MBX Biosciences, Inc.
MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member | |
Curzion Pharmaceuticals, Inc.
Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
Code Biotherapeutics, Inc.
Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Sorriso Pharmaceuticals, Inc.
Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Sorriso Pharmaceuticals, Inc. is an American biotechnology company that focuses on developing disease-modifying antibodies to treat inflammatory diseases. Sorriso Pharmaceuticals was founded by Ciara Kennedy, who has been the CEO since its incorporation. | Biotechnology | Director/Board Member | |
New Enterprise Associates, Inc. | Corporate Officer/Principal |
Statistiques
Internationale
Etats-Unis | 45 |
Canada | 4 |
Royaume-Uni | 2 |
Suisse | 2 |
Espagne | 2 |
Sectorielle
Health Technology | 36 |
Consumer Services | 6 |
Electronic Technology | 3 |
Finance | 2 |
Commercial Services | 2 |
Opérationnelle
Director/Board Member | 141 |
Corporate Officer/Principal | 65 |
Independent Dir/Board Member | 52 |
Chairman | 28 |
Chief Tech/Sci/R&D Officer | 25 |
Relations les plus connectées
Insiders | |
---|---|
Ed Mathers Mathers | 47 |
Robert Alexander Ingram | 43 |
George Abercrombie | 26 |
Roger Jeffs | 18 |
Rick S. Kent | 18 |
George Morrow | 16 |
Timothy Proctor | 16 |
Armando Anido | 16 |
James Anthony Ermilio | 15 |
David Savello | 13 |
William James Alexander | 12 |
H. Jefferson Leighton | 11 |
Reijo Juhani Salonen | 10 |
Seth V. Hetherington | 9 |
Michael V. Milburn | 9 |
- Bourse
- Insiders
- Alan Mark Rauch
- Connexions Sociétés